PACB—(-44%)—pre-announces flat 1Q24 revenue: https://www.prnewswire.com/news-releases/pacbio-announces-preliminary-first-quarter-2024-revenue-and-updates-2024-revenue-guidance-302117738.html Preliminary [1Q24] revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. I don’t follow the company closely, so I’m not sure if the revenue flatlining is company-specific or sector-specific.